Ask HopeStage to review this study with me
Leave your email and HopeStage can help you better understand this study.
Study reference: NCT04946916. HopeStage can help you review the study, but cannot decide medical eligibility.
RecruitingNCT04946916
Neurofilament Light Chains and Cognitive Impairment in Chronic Psychiatric Disease
This study is recruiting. It focuses on schizophrenia and currently lists participation information in France.
SchizophreniaDiagnostic TestFrom 45 Years to 80 Years
Key information made simple
This study is looking at care and outcomes for people with Schizophrenia, bipolarity, Alzheimer Disease, or Ftd. Taking part may give some people access to a digital support tool with regular follow-up, but direct benefit is not guaranteed.
Your next step
The official record suggests in-person participation through a hospital, with sites including HCL Consultation mémoire Neurologique -Hôpital Neurologique in Bron and Centre Hospitalier Le Vinatier in Bron. Participation appears to involve assessments along with scans or samples to help researchers understand patterns more clearly. The main fit is usually being able to understand the study and consent and meeting the main study requirements, while common reasons not to take part include active substance or alcohol problems that could affect the results and other factors that could make participation unsuitable. The official record does not list a formal phase, which usually means this is focused more on feasibility, delivery, or support than a standard drug-development stage.
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
- Sponsor
- Hôpital le Vinatier
- Sponsor type
- Hospital / academic medical center
- Main activity
- digital app or tool
- Intervention
- blood sample taken
- Time commitment
- long follow-up or multiple visits
- Study phase
- Not available
- Enrollment
- Not available
- Recruitment status
- Recruiting
- Source
- Official registry link
Key study information
- Official title
- Validation of Serum Neurofilament Light Chain as a Biomarker to Differentiate Cognitive Impairment From Neurodegenerative or Psychiatric Diseases
- Condition
- Schizophrenia; Bipolar Disorder; Alzheimer Disease; FTD
- Study status
- Recruiting
- Sponsor / lead affiliation
- Hôpital le Vinatier
- Intervention
- blood sample taken
- Location / country
- France
- Contact
- Dorey Jean-Michel, MD,PHD, SARTELET lydie, Maïté Formaglio, PH, Jean-Michel DOREY, MD, PHD
- jean-michel.dorey@ch-le-vinatier.fr, lydie.sartelet@ch-le-vinatier.fr, maite.formaglio@chu-lyon.fr
- Phone
- 0437915249, 0437915531, 04.72.35.76.62, 04 37 91 51 00
- Registry
- ClinicalTrials.gov
- External trial ID
- NCT04946916
Why this study may matter
This study may matter because it is evaluating blood sample taken in a structured research setting. For people exploring bipolarity research, clear information about the goal, status, contacts, and official source can support better questions before any decision.
For you
Taking part may help clarify how this condition is measured or understood.
It requires regular visits and structured follow-up.
Requires travel, with in-person participation in France.
Registry reference
This page links back to the public source record so people can verify details directly with the registry and research team.
If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.
- Official title
- Validation of Serum Neurofilament Light Chain as a Biomarker to Differentiate Cognitive Impairment From Neurodegenerative or Psychiatric Diseases
- Source
- ClinicalTrials.gov
- Official registry link
- Open official registry
- External trial ID
- NCT04946916
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is Neurofilament Light Chains and Cognitive Impairment in Chronic Psychiatric Disease?
This study is exploring digital app or tool for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed.
Who is behind this study, and what type of sponsor is it?
This study is sponsored by Hôpital le Vinatier. Based on the sponsor name or official registry information, it appears to be a hospital or academic medical center. You should verify the details in the official registry record.
What does participation involve, what phase is it, and what should I ask about safety?
This study may involve digital app or tool, study visits, and assessments. The time commitment is long follow-up or multiple visits. The study phase is not available in HopeStage data. Check the official source record to see whether a phase is listed. Enrollment is not available in HopeStage data. HopeStage cannot say whether a study is safe or right for you. Before joining, ask the research team about possible risks, time commitment, visits, side effects, compensation, safety monitoring, and whether participation may affect your current care.
Where can I verify the study details?
Use the official source record linked on this page to check the full study description, recruitment status, eligibility criteria, locations, sponsor information, phase, enrollment, contact details, and any listed risks or requirements.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me